BAM: Examination of Canned Foods | FDA


  • Production capacity: 35-75 t/h
  • Work pressure: 1.25-5.3 MPA
  • Applicable fuel: Bituminous coal, anthracite, meagre coal, lignite, gangue, waste, sludge
  • Applicable industry: Chemical, food, tobacco, textile, printing and dyeing, feed, medicine, building material, wine, rubber, hospital

Product introduction

  As a new mature high-efficiency and low-pollution clean coal technology, circulating fluidized bed combustion (CFBC) technology has many advantages that other combustion methods do not have. Circulating fluidized bed combustion is low-temperature combustion, so the NOx emission is much lower than that of pulverized coal furnace, only 200ppm. CFBC can desulfurize directly during the combustion process, and the desulfurization efficiency is high. The technology and equipment are simple and economic, and the costs of its initial investment and operation are much lower than those of dry pulverized coal furnace and flue gas desulfurization (PC+FCD). The discharged ash residue has good activity and is easy to be comprehensive utilized without secondary ash residue pollution. The load adjustment range is large, and the low load can be reduced to about 30% of the full load.

Quick inquiry:
I need the quotation of , the fuel is , this capacity is , the pressure is , use for . My Name is , my Email is , my phone number is , Please Send the detail information for me!

High temperature cyclone separator
  • High efficiency, wear resistance, separation efficiency ≥ 98%, effectively improve the combustion efficiency of the boiler thermal efficiency.

Large furnace design
  • Large furnace, low velocity design; the application of wearproof tube technology, reducing erosive abrasion.

  • Extend the residence time of coal particles in the furnace so that the coal can be fully burned.

Bell jar type hood
  • Adopt bell type hood to distribute air averagely and avoid fuel reverse to wind chamber.

Low bed pressure operation
  • By particle optimization, the operating bed pressure can be decreased to 3500Pa, which effectively saves operating costs and greatly reduces the oxynitride generated.

Model Rated Thermal Power t/h Working Pressure MPA Rated Output Water Temperature ℃ Thermal Efficiency %
DHX35-1.25-AⅠ 35 1.25 194 89
DHX50-1.25-AⅠ 50 1.25 194 89
DHX75-1.25-AⅠ 75 1.25 194 89
ZZ-35/3.82-AⅠ 35 3.82 450 89
ZZ-50/3.82-AⅠ 50 3.82 450 89
ZZ-65/3.82-AⅠ 65 3.82 450 91
ZZ-75/3.82-AⅠ 75 3.82 450 91
ZZ-75/5.3-AⅠ 75 5.3 485 91


FDA Approves Cyltezo, the First Interchangeable Biosimilar The FDA granted approval of Cyltezo to Boehringer Ingelheim on October 15, 2021. To date, the FDA has approved 31 biosimilar products, including two interchangeable products, for a variety of U.S. Food and Drug AdministrationThe FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the

Scientists question FDA on &39;scant&39; J&J booster data and FDA medical officer Dr. Timothy Brennan told the advisory committee that one of the trial&39;s examining the side effects of J&J&39;s booster had just 17 participants ages 18 to 55. Brennan said the

WATCH: FDA advisory committee debates Johnson & Johnson The FDA’s Vaccines and Related Biological Products Advisory Committee is expected to hold a meeting on Friday to discuss the emergency authorization of booster doses of the Johnson & Johnson FDA Panel Backs J&J COVID Booster : Shots - Health News : NPRFDA Panel Backs J&J COVID Booster : Shots - Health News A panel of experts voted to recommend that the Food and Drug Administration authorize a booster dose of the Johnson & Johnson COVID vaccine FDA vaccine panel recommends Moderna and J&J booster shots The FDA vaccine advisory panel is recommending booster shots for some Americans, and these recommendations will head to the FDA and CDC for further authorization. Dr. Ofer Levy, a voting member on

A new study on menthol cigarettes shows outsized harm to The FDA can only act if they have scientific evidence,” said Mendez, one of the author’s of the study. Advertisement “Enough is enough.

Follow the FDA advisory panel meeting on the J&J Covid Batting clean up, the FDA makes a mess. 4:40 p.m.: The panel ended the day with a wide-ranging discussion about two of the biggest issues facing vaccines in the real world: whether to allow so

FDA advisory committee votes to recommend Moderna COVID-19 FDA&39;s advisory committee will also vote on Friday (Oct. 15) whether to recommend a booster shot for the Johnson & Johnson COVID-19 vaccine, the third COVID-19 vaccine that&39;s approved in the U.S